Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb‐IIIa antagonists
Open Access
- 23 June 2004
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 2 (7), 1118-1126
- https://doi.org/10.1111/j.1538-7836.2004.00805.x
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Increased generation of platelet-derived microparticles following percutaneous transluminal coronary angioplastyBlood Coagulation & Fibrinolysis, 2003
- Abciximab Reduces Monocyte Tissue Factor in Carotid Angioplasty and StentingStroke, 2003
- High levels of circulating endothelial microparticles in patients with acute coronary syndromesAmerican Heart Journal, 2003
- Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-SelectinThe Journal of Experimental Medicine, 2003
- Comparison of Shear Stress–Induced Platelet Microparticle Formation and Phosphatidylserine Expression in Presence of αIIbβ3 AntagonistsJournal of Cardiovascular Pharmacology, 2003
- Intravascular tissue factor initiates coagulation via circulating microvesicles and plateletsThe FASEB Journal, 2003
- Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cellsNature Immunology, 2002
- Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction?. Insights from the PURSUIT TrialPublished by Oxford University Press (OUP) ,2002
- IIb’s are not IIb’sThe American Journal of Cardiology, 2000
- Networking in the Hemostatic SystemPublished by Elsevier BV ,1997